Kongo sermorelin review
By Ray Kaminski, who covers specialty pharmacy pricing and compounding economics.
Updated September 2026.
Not a partner — this company pays us nothing, and it is listed anyway.
“We start at $110” in the hero, while the plan selector lower on the same page reads $115/mo. It attacks its competitors by price — “Others charge $200+/mo” — which makes the five-dollar gap between its own two numbers worth noticing.
We are paid nothing if you sign up here.What that figure actually is
Kongo prints $110, per month. On this site that is a floor, not a rate — the distinction the board draws a different mark for, and the reason a figure here never appears on its own.
- The figure
- $110
- What kind of figure
- a floor, not a rate
- Billing cycle
- per month
- What it buys
- a nightly injection; dose not stated
- What the seller says is included
- licensed US provider review; prescription; compounding; free discreet shipping; syringes and injection supplies; no membership fee
- Read on
- September 2026
- Read from
- https://kongo.care/treatment/sermorelin
What else the page states
- Dose
- Not stated on the page we read. A subscription with no dose on it is half a price.
- How it is taken
- injection
- States served
- No state list on the page we read.
- Insurance, HSA and FSA
- The page we read says nothing about insurance, HSA or FSA.
- Pharmacy named for sermorelin
- None. No compounder is named on any sermorelin page we read. A pharmacy named on this company’s GLP-1 pages would not count here — it says nothing about who makes this drug.
- FDA action
- We have not established one. That is not the same as saying none exists: we match on a company’s domain and address rather than on a brand name, and no screen has been recorded against this company.
- Where the link goes
- Straight to this company’s own sermorelin page.
What Kongo discloses, scored
Scroll the table sideways for the remaining columns.
| What is scored | Earned | Out of | What the page shows |
|---|---|---|---|
| What kind of figure it publishes | 15 | 40 | $110, a “from” floor, not a rate |
| States the billing cycle | 15 | 15 | “per month”, in the seller’s own words |
| States the dose the price buys | 0 | 15 | no dose on the page we read |
| Itemises what the price includes | 10 | 10 | licensed US provider review; prescription; compounding; free discreet shipping; syringes and injection supplies; no membership fee |
| Names a pharmacy on a sermorelin page | 0 | 10 | no compounder named on any sermorelin page we read |
| States the states it serves | 0 | 5 | no state list on the page we read |
| Leaves no unlabelled figure on the page | 5 | 5 | every figure on the page carries what it is |
| Total | 45 | 100 | Higher means more of the price is on the page before you hand over an email address. |
Every line is computed from the fields on this page and summed; nothing is judged by hand. The score measures what the seller publishes, not whether it is cheap or whether the drug works.
Where Kongo sits
On the full board it is row 43 of 89. That board is ordered by what each seller states about its own figure and by nothing else — payment changes neither the price we publish nor where a row sits. Its disclosure score of 45 out of 100 is what orders the boards below, none of which is ordered by price.
It is on none of our boards: each one is a rule about what a seller publishes, and this page publishes none of those things.
We are paid nothing if you sign up here.Prices move. Everything above was read on September 2026 and is republished with that date attached; check the seller’s own page before you buy.